According to the Australian Institute of Health and Welfare, there are more than 1.7 million Australians that live with the biomedical signs of chronic kidney disease. While not all will deteriorate to kidney failure, it leads to the 22,000 deaths annually which could be reduced from earlier detection and better management, an initiative launched by
Read More
Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,
Read More
Australian semiconductor company Archer Materials (ASX: AXE) has developed a novel graphene transistor test that will produce the most stable and accurate gFETs for future development activities and commercialisation of their biochip for the medical diagnostics industry. The new procedure, designed to scrutinise the gFET sensors under various conditions and electrical operation modes, was developed
Read More
Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the commercialisation of their graphene-based Biochip, a recent design of which has been successfully manufactured by foundry partner Graphenea in Spain, carving a pathway towards its future production. The milestone advances Archer’s Biochip capabilities in access to commercial semiconductor production facilities for technologies
Read More
If you’re somewhat versed in the tech world, you have probably heard terms like semiconductors, quantum computing and bioelectronics, and their potential to change the world. While some companies might suggest that these have a long way to go before they are usable by the layman, Archer Materials is readying to inject them into our
Read More
Working closer towards commercialising its cutting-edge graphene Biochip, semiconductor company Archer Materials (ASX: AXE) has dispatched its latest chip design iteration to a certified foundry in Spain for fabrication through a whole wafer manufacturing run. This move is part of Archer’s ongoing commitment to pushing the boundaries in both quantum computing and medical diagnostics while
Read More